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Essentially all of the cellular immune elements and processes that have been 
identified can be stimulated in vitro by the addition of exogenous plant lectins. 
Various lectins have been shown to induce T  cell proliferation; T  cell, K  cell, 
polymorphonuclear leukocyte, and macrophage cytotoxic effector function; lym- 
phokine secretion; helper activity; suppressor activity; B cell proliferation; and 
differentiation of B cells for immunoglobulin secretion (1-6). 
Lectins bind to specific carbohydrate sequences and are thought to activate 
cells by interaction with the carbohydrate portion of endogenous glycoprotein 
and glycolipid receptors on  the cell membrane, which are critical for cellular 
activation. Such activation by plant lectins can be prevented when large excesses 
of an appropriate saccharide are added to compete with lectin binding to these 
cell surface glycolipid and glycoprotein receptors. 
Lectin-like molecules are not restricted to  the plant  kingdom.  Invertebrate 
hemolymph  is  a  rich  source  for  such  carbohydrate-specific molecules (7-8). 
Increasing evidence is accumulating which demonstrates that  lectins or sugar- 
binding receptor structures are present on many types of vertebrate cells as well. 
For example, fibroblasts express receptors with specificity for mannose-6-phos- 
phate and hepatocytes have a receptor for galactose (9,  10). Endogenous lectins 
have also been shown to modulate a number of in vitro immunologic reactions. 
For  example,  the,Jymphokine  migration  inhibitory  factor  (MIF)  binds  to  a 
fucosidase-sensitive receptor on the macrophage surface (11). The activity of the 
cytokines SISS-T and SISS-B (soluble immune suppressor substances of T  and B 
cells, respectively) is blocked by their interaction with specific monosaccharides, 
N-acetyl-D-glucosamine  and L-rhamnose, respectively, and suppressor T  cells that 
are activated during infectious mononucleosis are inhibited by r)-mannose and 
related sugars (12,  13). 
D-Mannose also has a  number of other immunoregulatory effects in vitro: it 
inhibits spontaneous monocyte cytotoxicity toward certain erythrocyte targets, 
it  blocks  natural  cytotoxicity (NC) ~ but  not  alloimmune  cy{otoxicity, and  it 
inhibits  natural  killer activity but  not antibody-dependent cytotoxicity toward 
Abbreviations  used  in  this paper:  Con  A, concanavalin A; a-D-Manp  l-6-D-Man, C~-D-mannopy- 
ranoside 1-6-D-mannose; NC, natural cytotoxic; TLC, thin-layer chromatography. 
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identical  targets  (14-16).  D-Mannose  has  also  been  shown  to  inhibit  antigen- 
induced human T  lymphocyte proliferative responses in vitro (17). Interestingly, 
a  mannose  polymer  from  yeast  mannan  also  is  inhibitory  to  human  T  cell 
proliferation, and  an  immunosuppressive  substance  found in the serum  of pa- 
tients with chronic mucocutaneous candidiasis has been identified as this fungai 
product (18). 
Even from these early studies with defined sugars, it appears that their effects 
are almost as protean as those of plant lectins. However, studies using sugars like 
D-mannose  suffer from  several  major disadvantages.  First,  in  vitro effects are 
only seen using very large molar concentrations of sugar (i.e.,  10-50 mM) and, 
second,  some sugars  like L-rhamnose have very interesting in vitro effects but 
are  not  found  on  mammalian  glycoproteins.  To  address  these  problems,  we 
sought  a  source  of readily  available  saccharides  that  would  be  amenable  to 
purification and might be more specific in their actions. 
Human pregnancy urine is known to contain immunoregulatory factors (19). 
Furthermore, urine is a  rich source of complex saccharides.  As part of a  larger 
study characterizing the immunoregulatory effects of human pregnancy urine, 
we noted that  low molecular weight fractions of human  pregnancy urine were 
immunosuppressive  in  vitro.  We  have  characterized  one  of these  factors and 
found that it is an a-D-mannopyranoside  1-6-D-mannose (a-D-Manp  1-6-D-Man) 
dimer capable of blocking early events necessary for an antigen-specific T  cell 
response. Furthermore, this mannose dimer is in excess of 100 times more potent 
than its parent D-mannose. 
Materials and Methods 
Source of Human Pregnancy  Urine.  Freshly obtained, first-void morning samples from 
individuals between 20 and 40 wk of gestation were frozen at -20°C before use. 
Reagents.  Concanavalin A  (Con A) Sepharose was purchased from Pharmacia Fine 
Chemicals (Uppsala,  Sweden).  RPMI  1640 and balanced salt  solution were purchased 
from Microbiological Associates (Bethesda, MD). Tetanus toxoid was purchased from the 
Massachusetts  Department of Public Health,  Boston.  Fractogel 40S (a rigid molecular 
sieving gel) was purchased from EM Science (Gibbstown, N  J). 
Antigen-specific Proliferative Assays.  Briefly, heparinized peripheral blood (preservative- 
free heparin, ~10U/cc; O'Neal, Jones and Feldman, St. Louis, MO) was centrifuged for 
5 min at  100 g and the buffy coat was collected. The buffy coat was washed once with 
balanced salt solution and then 2 ×  105 cells in 0.15 cc RPMI  1640 supplemented with 
10%  autologous plasma and  2  mM  L-glutamine were added  to flat-bottomed, 96-well 
tissue culture plates (Costar, Data Packaging, Cambridge, MA). 0.05 cc of an appropriate 
dilution of tetanus toxoid or tissue culture media was added and the plates were allowed 
to incubate in a humidified 5% CO~ incubator at 37°C for 6 d. These cells were pulsed 
with 0.5 uCi tritiated thymidine, allowed to incubate a further 4.5 h, and then harvested 
on filter paper disks and counted for tritiated thymidine incorporation. 
Analytical Procedures.  Sugar and methylation analyses were carried out as previously 
described (20-22). Gas liquid chromatography/mass spectrometry was carried out on a 
Finnigan 4021  chromatograph (Finnigan MAT, San Jose, CA) equipped with an SE-30 
wall-coated open tubular (W.C.O.T.) capillary column (25 m  ×  0.2 mm).  Mass spectra 
were  recorded at  70  eV  with  an  ionization  current  of 0.3  mA  and  an  ion  source 
temperature of 200°C.  Spectra were processed on a  Nova 3 on-line computer system 
(Data General Corp., Westboro, MA). 
Source of Sugars.  D-Mannose and methyl-a-~mannopyranoside were purchased from 
Sigma Chemical Co.,  (St.  Louis,  MO).  Most  lots of methyi-a-~mannopyranoside were 1674  HUMAN  PREGNANCY  URINE  MANNOSE-CONTAIN1NG  DISACCHAR1DE 
shown  to  be  homogeneous  on  high  performance  thin-layer  chromatography  (TLC); 
occasionally, trace contaminants with the migration  characteristics  of D-mannose could be 
detected on overloaded plates. 
TLC  was performed  using 10-  x  20-cm,  high  performance  silica gel  plates  with  a 
preabsorbant loading area (Whatman  Laboratory Products Inc., Clifton, N  J). Plates were 
developed with Orcinol spray reagent (Sigma Chemical Co.). 
Results 
Initial screening experiments suggested that immobilized Con A  was capable 
of retaining immunoregulatory factors found in human pregnancy urine.  Thus, 
our purification scheme was biased toward mannose-containing compounds. 
15 d of first-void morning urine (~3 liters) from individual donors was passed 
over  Con  A  Sepharose  columns  (35  cc  bed  volume,  500  ml  urine)  at  room 
temperature.  The  columns  were washed with  two-bed volumes of phosphate- 
buffered saline  containing  1 mM  MnC12; they were then  eluted with  two-bed 
volumes of phosphate-buffered saline containing 250 mM methyl-a-D-mannoside. 
This  material  was pooled and  lyophilized, and  the majority of the methyl-a-D- 
mannoside  was removed on a  5  x  100 cm Sephadex G-10 column eluted with 
distilled water and monitored for both OD 280 and change in refractive index. 
The  protein-rich  fraction  was pooled,  lyophilized,  and  redissolved  in  0.01  M 
ammonium acetate buffer, pH 4.75. This material was placed on a  2.6 x  90 cm 
Sephadex G-75 column and  eluted with acetate buffer. The elution pattern  of 
this purification step resulted in four distinct peaks (Fig.  1). Each of these peaks 
was collected and  lyophilized to dryness to remove volatile ammonium  acetate 
(which is nonspecifically toxic to lymphocyte function in vitro).  Each peak was 
then reconstituted to an equal volume in distilled water and tested for its effects 
on antigen-specific lymphocyte proliferation  (Fig.  1). Peak IV, which contained 
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FIGURE  1.  Elution pattern of lyophilized material from fraction I. This represented 350 mg 
of protein. Stippled bars show relative inhibition of each of the pooled fractions as described 
in the text. MUCHMORE  ET  AL.  1675 
smaller molecular weight components, was consistently immunosuppressive and 
was further characterized. 
Concentrated material from peak IV was placed on a  1.5 ×  165 cm Fractogel 
40S  column (a  recently available  molecular sieving  chromatography reagent 
based  on  rigid  porous  polyvinyl beads)  and  eluted with  distilled  water.  The 
elution profile of this peak IV material was complex and varied from donor to 
donor. A  representative pattern is shown in Fig.  2.  Each fraction was concen- 
trated by lyophilization and tested for its ability to inhibit T  cell proliferation 
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FIGURE 2.  Elutionpattern of fraction IV (3 cc containing 10.2 mg sugar and 3.6 mg protein) 
from Fig. 1 run over a  1.5 ×  165 cm Fractogel 40S column eluted with distilled water. Each 
fraction was lyophilized  and reconstituted with distilled water to 1 cc. The sugar concentrations 
were: I, 2.8 mg; II, 2.2 rag; III,  1.2 mg; IV, 0.4 mg; V, 0 rag; VI, 0 mg. 
TABLE  I 
Bioactivity of Fractogel 40S Fractions 
Percent 
Fraction  Concentration  cpm  inhibition 
mg/ml 
I  0.014  8,474  35 
II  0.011  7,884  40 
III  0.006  9,963  25 
IV  0.002  17,589  <0 
V  0.0  10,270  22 
VI  0.0  13,100  0 
Fractions from Fig. 2 were pooled and lyophilized to complete dryness and then 
reconstituted with distilled water. The sugar concentration of each was deter- 
mined using  the cysteine sulfuric acid  method and  is  expressed as  the  final 
concentration in the culture supernatant. These cultures were stimulated with 
tetanus toxoid and allowed to incubate for 6 d.  Results represent the mean of 
triplicate determinations and are expressed as counts per minute (cpm). Cultures 
without added sugar gave  13,114 cpm; those without added antigen gave  148 
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induced by the antigen  tetanus toxoid.  Table I depicts representative data from 
one  of  three  similar  experiments.  Fractions  I-III  reliably  inhibited  tetanus 
toxoid-induced proliferation, with fraction II showing the most inhibitory activ- 
ity.  Experiments  with  other  individual  urine  donors  had  shown  activity  in  a 
similar area and  with  a  similar TLC  pattern,  so fraction  II was further charac- 
terized.  Fig.  3 shows a  high performance thin-layer chromatogram of fraction II 
run on silica in  ethanol/butanol/water,  40:40:20.  An  unstained  TLC  plate run 
in  parallel  was divided  into  four fractions as shown  in  Fig.  3  and  the  fractions 
were eluted with a  mixture of water/ethanol,  75:25,  and lyophilized to dryness. 
Each fraction was tested for bioactivity in the tetanus  toxoid proliferation assay 
(Table II). The material in fractions I and II showed the most activity. Fraction 
II was then rechromatographed and shown to be homogeneous on high-perform- 
ance  TLC  with  an  Rf of 0.49  (Fig.  4).  Homogeneous  material  with  identical 
migratory characteristics was obtained and subjected to structural analysis. 
Sugar analysis showed D-mannose as the monosaccharide present. The material 
was reduced with NaBD4, permethylated, and analyzed by gas chromatography/ 
mass  spectrometry.  The  mass  spectrum  is  shown  in  Fig.  5.  The  primary and 
secondary  fragments  m/z  219,  m/z  187,  and  m/z  155  are  characteristic  for a 
nonreducing terminal hexose residue. The ion m/z 236 shows an NaBD4-reduced 
FIGVR. 3.  High performance thin-layer chromatography of fraction II ti'om Fig. 2 run with 
butanol/ethanol/water,  40:40:20, and developed with Orcinol. 
TABLE  lI 
Bioactivity of TLC Fractions 
Area 
Volume added 
1 #1  0.2  #1 
I  67  73 
II  17  41 
III  41  87 
IV  106  96 
An unstained TLC was run in parallel with Fig. 4, starting with a total of 
100 #g of fraction ll from Fig. 3. The chromatogram was developed with 
ethanol/butanol/water,  40:40:20, and each fraction was scraped, eluted, 
and lyophilized to dryness. The fractions were reconstituted  to 50 ~l,  1 
#l, and  1 #l of a  1:5 dilution  and were added  to the standard  antigen 
proliferation  assay. Results are expressed as a percent  of the  untreated 
cultures. MUCHMORE  ET  AL.  1677 
FIGURE 4.  Rechromatographed sample of fraction II from Fig.  3 run under similar condi- 
tions. 
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Mass spectrum of the disaccharide alditol from fraction If. Primary fragments are 
hexose. Fragments formed by cleavage within the alditol m/z  134, m/z  178, m/ 
z 293,  m/z  337, and  m/z  381  show that  the reduced terminal  is substituted in 
the 6 position.  Thus,  two D-mannose derivatives were observed, representing a 
nonreducing  moiety and  a  6-O-substituted n-mannitol.  The  anomeric  configu- 
ration must be 0t, since the compound bound to Con A Sepharose. The deduced 
structure must therefore be ~-D-Manp  1-6-D-Man. 
As an  independent approach  to determining  whether this mannose  disaccha- 
ride isolated from urine was indeed an immunosuppressive molecule, this com- 
pound,  isolated  and  purified  from  an  entirely different  source,  was tested  for 
bioactivity in  the  T  cell  proliferative  assay,  a-D-Manp  1-6-D-Man  was purified 
from yeast cell wall extracts as previously described (23).  Fig. 6 compares the in 1678  HUMAN  PREGNANCY  URINE  MANNOSE-CONTAINING  DISACCHARIDE 
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FIGURE 6.  Relative inhibition of the urinary mannose 1-6 mannose compared with the yeast- 
derived material. For comparison, D-mannose is also shown. Results are expressed as percent 
inhibition compared with the untreated controls in each experiment. The yeast values repre- 
sent  the  average  of four  separate  experiments;  the  urine-derived  material  represents  the 
average of two experiments. 
vitro effects on T  cell proliferation of these two independently purified mannose 
disaccharides. 
Thus,  we have shown  that  ~x-D-Manp 1-6-o-Man  is capable of modulating  in 
vitro  T  cell  responsiveness  to  the  recall  antigen  tetanus  toxoid.  A  series  of 
experiments was then undertaken  to further characterize the cellular specificity 
of this inhibition.  In data not shown, inhibition by a-D-Manp  1-6-D-Man  failed to 
demonstrate any apparent antigen specificity, since in vitro responsiveness to the 
antigens tetanus toxoid, candida, and streptokinase-streptodornase was inhibited 
to  a  similar  extent.  However, this  mannose  dimer  had  dramatically  different 
effects on  assays  measuring  monocyte  or  B  cell  reactivity.  These  results  are 
summarized in Table III. Part I of Table III examines the in vitro induction of 
spontaneous  monocyte-mediated cytotoxicity (24,  25).  This  assay of monocyte 
cytotoxicity is exquisitely sensitive to a  variety of exogenous stimuli,  including 
sugars,  chemotherapeutic  agents,  mitogens,  and  anti-inflammatory  drugs  (16, 
26-28).  At the concentrations we employed, D-Manp  1-6-D-Man  failed to affect 
monocyte cytotoxicity in either a  negative or positive fashion.  Part II of Table 
III  examines  the  effect  of this  mannose  dimer  on  the  expression  of reverse 
hemolytic plaque-forming cells using pokeweed mitogen as a stimulus (4).  Inter- 
estingly, o~-o-Manp  1-6-o-Man had no inhibitory effect in this assay as well. The 
effect of a-D-Manp  1-6-D-Man on pokeweed mitogen-induced cellular prolifer- 
ation was examined in a  companion series of experiments.  In contrast to the B 
cell assay, this mannose dimer was inhibitory for cellular proliferation  induced 
with pokeweed mitogen. 
Finally, experiments were performed to further characterize the inhibition of 
antigen-specific T  cell proliferation seen with this  1-6 dimer of mannose and to 
exclude toxicity as a trivial explanation of our results. First, no differences were 
seen in cell viability, whether or not a-D-Manp  1-6-D-Man was added for 24 h to 
the cultures (data not shown). More importantly, kinetic studies of the timing of 
a-t)-Manp  1-6-D-Man  addition  to  these  cultures  strongly argue  against  simple 
metabolic or toxic effects. Thus, Table IV shows that when this sugar is added 
to mononuclear cell cultures after 24 h of a  144 h culture period, no inhibitory MUCHMORE  ET  AL. 
TABLE  III 
Effect of Dimer on Monocyte and B Cell Function 
1679 
Concentration of v-Manp 1-6-D-Man 
375 #M  75 t~M  None 
(I)  Spontaneous monocyte-mediated cytotoxicity 
Percent 51Cr release:  76  76  71 
(I1)  Total reverse hemolytic plaque-forming cells 
750 uM  375 ~M  None 
Plaque-forming cells]culture:  19,700  19,600  20,500 
(III)  Proliferation to pokewood mitogen 
750 ~M  None 
cpm (5 ×  104 MNL):  54,200  79,200 
cpm (2.5 x  104 MNL):  18,600  35,500 
Effect of 1-6 mannose dimer on various in vitro assays. Spontaneous monocyte-mediated  cytotoxicity 
was  performed  exactly as previously described (24).  Briefly, 7  x  l0  s  Ficoll-Hypaque-separated 
peripheral blood mononuclear cells are incubated for 7 d in NCTC  109 medium with 2% added 
fetal calf serum.  The  inhibitory disaccharide was  added at  the  initiation of culture.  Cytotoxic 
monocytes are harvested on the 7th d and assayed for spontaneous cytotoxicity against chicken red 
blood cell targets. Results represent the mean of triplicate determinations and are expressed as 
percent 5'Cr release. Total reverse hemolytic plaque-forming cells were enumerated after 6 d  of 
stimulation with  pokeweed mitogen as previously described (4).  This assay  measures polyclonal 
stimulation by pokeweed mitogen. The cultures consisted of 2 x  105 human mononuclear cells on 
flat-bottomed microtiter dishes with added pokeweed mitogen and 10% fetal calf serum. Results are 
expressed as plaque-forming cells per culture and represent the mean of triplicate cultures. Prolif- 
eration to pokeweed mitogen was measured in the same way that tetanus toxoid proliferation was 
measured except that (a) the polyclonal mitogen was added instead of specific antigen, and (b) fewer 
responding mononuclear lymphocytes (MNL) were used because the response to pokeweed mitogen 
was suboptimal at 2 x  105 cells per microtiter well in a 6-d assay. 
TABLE  IV 
Functional ldentity of Urinary and Yeast-derived Disaccharides 
Source  No addition  Day 0  Day 1 
Urine  19,708  4,562  18,615 
Yeast  12,237  3,433  11,282 
Results of two independent experiments examining the kinetics of inhibi- 
tion by a-D-Manp  1-6-~Man. Two sources were used, the first purified 
from human pregnancy urine and the second independently purified from 
yeast cell  walls.  In  each  experiment,  human  mononuclear  cells  were 
stimulated with tetanus toxoid antigen and the dimer was added either at 
time zero or after 24 h of culture (final concentration, 750 t~M). 
activity is observed.  This observation not only makes toxicity unlikely, but also 
demonstrates  that  this  disaccharide  must  be  interfering  with  a  very early  step 
required  for normal antigen-specific T  cell proliferation to occur. Thus, by 24 h 
of  culture,  when  accelerated  DNA  synthesis  has  not  yet  become  apparent, 
addition of sugar is no longer capable of inhibiting T  cell proliferation. 
Finally, Table  V  suggests that this early inhibition requires cellular collabora- 
tion. Interestingly, preincubation of either enriched monocytes or highly purified 
lymphocytes  with  dimer  for  24  h  has  no  effect  on  their  subsequent  ability to 1680  HUMAN  PREGNANCY  URINE  MANNOSE-CONTAINING  DISACCHARIDE 
TABLE  V 
Effect of Preincubation with 1-6 Mannose Dimer 
Source of cells 
Thymidine incorporation 
Experiment 1  Experiment 2 
cpm 
Unseparated (media)*  85,261  11,739 
Unseparated (dimer)  19,982  4,470 
Lymphocytes (media) + monocytes (dimer)  80,895  12,335 
Lymphocytes (media) + monocytes (media)  69,998  11,296 
Lymphocytes (dimer) +  monocytes (media)  72,545  13,937 
Lymphocytes (dimer) +  monocytes (dimer)  74,468  ND 
Peripheral blood mononuclear cells  were separated  into monocyte-enriched 
and  monocyte-depleted preparations using adherence  to  plastic  dishes  and 
subsequent passage over Sephadex G-10 columns as previously described (27). 
The  lymphocyte-enriched populations had <1%  monocytes and did not re- 
spond to soluble antigen without the addition of monocytes (<300 cpm for 
experiments 1 and 2). These various cell populations were then preincubated 
in either media or 750 ttM of the mannose dimer for 20 h. 
* Experiment  1 preincubated unseparated cells,  whereas experiment 2  used a 
mixture of 20% monocytes, 80% lymphocytes instead of unseparated cells to 
control for potential removal of a subpopulation of cells. The pretreatment is 
noted in parentheses. After preincubation, the various cell populations were 
washed  twice  with  media and resuspended in fresh  media without further 
addition of dimer. The cell populations were then mixed as noted and assayed 
for  tetanus toxoid  induced thymidine incorporation after  6  d.  Results are 
expressed as counts per minute of quadruplicate (experiment 1) or triplicate 
(experiment 2) determinations. Background in the absence of added antigen 
was <200 cpm. 
either present antigen or proliferate after being washed free of dimer. However, 
preincubation  of these  two subpopulations  together  with  dimer  renders  them 
incapable of mounting a normal antigen-specific proliferative response. 
Discussion 
Human pregnancy urine is a rich and complex source of both large and small 
molecular weight saccharides and glycoproteins with immunoregulatory activity. 
We have purified and characterized an 0~-D-Manp 1-6-D-Man  disaccharide  from 
human pregnancy urine capable of blocking early events required for an in vitro 
proliferative response to specific antigen.  Material with an Rr of 0.48-0.51  (in 
ethanol/butanol/water,  40:40:20)  was purified  from  three  separate  individual 
donors and in each  instance it was immunosuppressive in vitro.  However, a-D- 
Manp 1-6-D-Man  is not the only immunoregulatory, small molecular weight sugar 
found in human pregnancy urine, and each of three individual donors exhibited 
different patterns of sugar excretion. Several low molecular weight saccharides, 
as well as at least two larger molecular weight glycoproteins, affected our bioassay. 
Because of the complex bioactivity of even partially purified pregnancy urine, it 
is not possible to calculate a  starting  specific activity or an  estimate  of overall 
yield,  since  contaminants  other  than  a-D-Manp  1-6-D-Man  can  also affect  the 
bioassay system.  Furthermore,  the variability in the patterns of sugar recovery 
that we observed suggests that c~-D-Manp 1-6-D-Man  may represent a by-product 
derived  from  a  more  complex  glycoprotein  or  glycolipid;  however,  our  data MUCHMORE ET  AL.  1681 
conclusively argue that  a-o-Manp  1-6-D-Man  may have important  effects on in 
vitro  antigen-specific  proliferation.  Fig.  6  demonstrates  that  ot-D-Manp  1-6-D- 
Man,  compared with D-mannose,  has a  much broader dose-response range and 
therefore the inhibitory curve has a different slope. Because of this quite different 
rate  of change,  estimates  of relative  potency are  somewhat  arbitrary.  If one 
accepts 50%  inhibition  as a  comparative  point,  then  mannose  1-6  mannose  is 
~100  times  more  potent  than  O-mannose;  if,  however,  one  compares  30% 
inhibition,  then a-D-Manp  1-6-D-Man is almost 500 times more potent. 
Mannose-a-l-6  linkages are quite common in human  mannose-rich  glycopro- 
teins; however, they tend to be proximal with respect to the protein  moiety. A 
number of mammalian glycoproteins, including serotransferrin,  iactotransferrin, 
fetuin,  prothrombin,  al-acid  glycoprotein,  and  thyroglobulin,  will  yield  a-o- 
Manp  1-6-D-Man on degradation.  Furthermore,  accumulation of this dimer has 
been  reported  in  the  storage  disease fucosidosis and  G.M.  gangliosidosis  (29). 
The  exact cellular  mechanism  by which  a-o-Manp  1-6-D-Man  acts to suppress 
antigen-specific proliferation  remains  to be determined,  however. The  kinetics 
of inhibition  of a-D-Manp  1-6-D-Man  are  different  from  those  seen  using  D- 
mannose.  Addition  of D-mannose  inhibits  T  cell  proliferation  throughout  the 
culture period,  whereas 0t-D-Manp  1-6-D-Man  inhibits  only when  added at the 
initiation  of culture.  These data suggest that a requisite monocyte/T cell inter- 
action  or,  alternatively,  a  recruiting  or  amplifying  factor  is  being  blocked. 
Furthermore,  since mannose  1-6 mannose has very little effect when added late 
during culture, these kinetics suggest that the mannose  1-6 dimer is unlikely to 
be acting as a general metabolic inhibitor. 
In  fact,  data  in  Table  III  suggest  that  a-D-Manp  1-6-D-Man  may  have  a 
preferential  effect on  T  cell  proliferation.  Thus,  the  dimer  had  no  apparent 
effect on  the  in  vitro  induction  of human  spontaneous  monocyte cytotoxicity. 
This assay is quite sensitive to the addition of exogenous agents that can affect 
monocyte function. For example, pokeweed mitogen and antisera to Dr antigens 
dramatically inhibit this assay while cis platinum, X irradiation, and phenylalanine 
mustard via different mechanisms actually enhance cytotoxicity (26-28, 30, 31). 
Not  only  did  this  mannose  dimer  fail  to  inhibit  the  generation  of cytotoxic 
monocytes, but it also failed to inhibit the generation of antibody-secreting cells 
as assayed with a reverse hemolytic plaquing assay using pokeweed mitogen as a 
stimulant.  Interestingly,  the dimer did inhibit  cellular proliferation  induced by 
pokeweed  mitogen.  Since  pokeweed  mitogen  is  both  a  T  cell  and  a  B  cell 
mitogen,  the fact that  it inhibits  proliferation  without reducing  the number of 
observed plaque-forming  cells  suggests  that  a-D-Manp  1-6-D-Man  may have  a 
preferential effect on T  cell recruitment and proliferation, while having little or 
no effect on B cell proliferation and function.  In an effort to dissect this effect 
on T  cells further,  mixture experiments were performed. 
Table V  shows that  mannose  1-6  mannose does not act on either monocytes 
or  T  cells  individually,  but  requires  that  both  cell  types  be  present.  Thus, 
preincubation of whole mononuclear cell populations with mannose 1-6 mannose 
for  20  h,  followed by washing  of the  cells and  reconstitution  in  fresh  media, 
results in  suppression  of a  6-d antigen  proliferation  assay.  Interestingly,  prein- 
cubation of either monocytes by themselves or highly purified lymphocytes with 1682  HUMAN PREGNANCY URINE MANNOSE-CONTAINING DISACCHARIDE 
0~-D-Manp 1-6-D-Man  fails  to  inhibit  the  activity  of either  cell  population  to 
support normal antigen proliferation, even when the two pretreated cell types 
are  remixed after  24  h.  Thus,  the  first  24  h  of the  assay are  critical;  both 
monocytes and iymphocytes must be physically together, and the mechanism of 
action does not appear to be trivial or a general metabolic phenomenon. 
The  fact that  suppression  is  seen  at  micromolar concentrations argues  for 
some specificity in the ability of a-D-Manp  1-6-D-Man  to alter in vitro immuno- 
logic reactions. However, it is important to point out that several other fractions 
from human pregnancy urine are also inhibitory. We have not studied normal 
urine for similar immunoregulatory molecules, but we suspect that it, too, will 
contain molecules of interest. 
I>Mannose has been previously shown to interfere with a  variety of in vitro 
reactions. For example, D-mannose blocks receptor-mediated uptake of certain 
enzymes (9). Furthermore, ~mannose has been reported to block NC, to inhibit 
antigen-specific proliferation, to block spontaneous monocyte-mediated cytotox- 
icity, and to reverse inhibition of in vitro immunoglobulin synthesis mediated by 
T  cells found in the circulation of patients with infectious mononucleosis (13). 
Yeast mannan is also known to inhibit antigen-specific proliferation, and it has 
been proposed that certain patients with chronic mucocutaneous candidiasis fail 
to respond normally to antigen stimulation because of circulating mannan (18). 
In  this  regard,  it  is  interesting to  note  that  ~-D-Manp  1-6-D-Man  is  a  major 
linkage found in  many mannans.  Furthermore, we have preliminary evidence 
that complex mannose oligosaccharides composed primarily of D-mannose-a-1-6 
linkages  are  dramatically  more  inhibitory  than  the  simple  dimer,  and  these 
compounds seem  to  share  similar kinetics  with  the  dimer.  This  implies  that 
multivalency may be very important. 
In conclusion, we believe that plant lectins are able to activate the immune 
system by binding to physiologic glycoprotein and glycolipid receptors. In the 
same way that exogenous lectins have been widely employed to activate various 
immunologic reactions, we propose that careful study of the effects of defined 
sugars will be equally illuminating. The 1-6 dimer of D-mannose that we describe 
already shows an affinity and immunologic specificity not exhibited by its parent, 
D-mannose. Thus,  sugars  like  a-D-Manp  1-6-D-Man  may begin  to  be  used as 
probes  to  interfere with  the function of endogenous lectin like activity in  an 
effort to further dissect cell-mediated immune responses in vitro. 
Summary 
Endogenous mammalian lectin-like sugar-binding molecules have been previ- 
ously described that have immunoregulatory properties.  Further, the addition 
of defined simple saccharides to lymphocyte cultures has been shown to inhibit 
a variety of in vitro lymphocyte functions, presumably because these sugars are 
able to compete with the binding of endogenous lectins to critical membrane 
receptors. In this report, we describe the isolation and characterization of a  D- 
mannose-containing disaccharide in  human pregnancy urine that  inhibits  the 
proliferative response of human T  lymphocytes. The inhibitory disaccharide was 
purified to homogeneity by sequential steps including affinity chromatography 
on  immobilized concanavalin A  and  molecular sizing on  Sephadex G-75  and MUCHMORE  ET  AL.  1683 
then Fractogel 40S columns, with final purification on high-performance thin- 
layer  chromatography.  By  mass  spectrometry  of the  purified  material  as  its 
permethylated derivative, the deduced structure of this compound was a-D-Manp 
1-6-D-Man. To confirm that this disaccharide was in fact immunosuppressive, an 
identical  disaccharide  was  prepared  by  sequential  digestion  of yeast  cell  wall 
polysaccharide. The urinary and yeast disaccharides had identical immunosup- 
pressive properties. It has been previously reported that D-mannose is inhibitory 
for antigen-specific proliferative assays in the range of 10-50 mM. The purified 
a-D-Manp  1-6-D-Man  disaccharide was  inhibitory at  100-fold-lower  concentra- 
tions.  Further,  while  D-mannose  inhibits  T  cell  proliferation  when  added  at 
anytime up to 24 h before harvest of a 6-d lymphocyte culture, a-D-Manp  1-6-D- 
Man disaccharide was inhibitory only if added at the initiation of culture and 
had no inhibitory effect if added just 24 h later. These data support the concept 
that simple sugar compounds can exhibit marked immunoregulatory activity in 
vitro. The impact of these molecules on the regulation of immune responses in 
vivo  is  unknown,  as  is  their  precise  mechanism  of action,  but  structural  and 
chemical identification should now permit a detailed analysis of these issues. 
We wish to thank Dr. Clinton E. Ballou for the very generous gift of purified 1-6 mannose 
dimer obtained from yeast mannoprotein and for very helpful discussion. 
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